U.S. Communications Stock News

Tyra Biosciences, Inc. recently reported first-quarter 2026 results showing a wider net loss of US$39.31 million and basic loss per share of US$0.64, while highlighting progress across three Phase 2 trials for its lead candidate dabogratinib and a cash balance of US$383.5 million supporting operations into the second half of 2028. An interesting angle for investors is how Tyra’s “dabogratinib 3×3” plan concentrates resources on three FGFR3-driven indications, potentially shaping its future...

Humacyte (HUMA) is back in focus after Q1 2026 results highlighted continued losses alongside restructuring moves, new leadership, fresh international agreements, and upcoming clinical readouts that could influence how investors view the stock. See our latest analysis for Humacyte. The share price has been volatile, with a 1 month share price return of 26.36% but a 1 year total shareholder return that is down 58.48%. This reflects shifting sentiment as investors weigh fresh capital raises,...

Rubber Leaf (OTCPK:RLEA) opened 2026 with Q1 revenue of about US$3.3 million and basic EPS of roughly US$0.01, with the stock trading around US$4.50. Over recent periods, the company has seen quarterly revenue range from US$0 to about US$3.3 million while basic EPS has moved between a loss of roughly US$0.01 and a gain of just under US$0.01. This gives investors a clear view of how sensitive margins have been to shifts in activity levels. See our full analysis for Rubber Leaf. With the...

Why Clarivate’s New AI Platform Matters for the Stock Clarivate (CLVT) has launched Web of Science Research Intelligence, an AI-native platform built with research institutions to combine curated data, impact metrics, and workflows across funding, collaboration, and research assessment. For shareholders, this fresh product sits at the heart of Clarivate’s existing research and intellectual property data assets, raising questions about adoption, pricing power, and how it may influence...

Old Dominion Freight Line (ODFL) has drawn fresh attention after reporting quarterly revenue of $1.33b, which declined 2.9% year on year but came in ahead of expectations, alongside accelerating less than truckload volumes and improved yield. See our latest analysis for Old Dominion Freight Line. At a share price of $203.12, Old Dominion Freight Line has delivered a 27.6% year to date share price return and a 19.42% total shareholder return over the past year, with shorter term moves...

Bentley Systems (BSY) has just launched NXT Activate with NXT BLD, a developer accelerator aimed at early stage AEC software startups, putting the company’s broader ecosystem strategy in sharper focus for investors. See our latest analysis for Bentley Systems. Despite the NXT Activate launch and recent first quarter earnings update, Bentley Systems’ share price is around US$32.07, with the 30 day share price return down 5.82% and the 1 year total shareholder return falling 32.73%. This hints...

In May 2026, Archer-Daniels-Midland reported first-quarter sales of US$20,490 million and net income of US$298 million, modestly above the prior year, raised its full-year adjusted earnings guidance, affirmed a quarterly dividend of US$0.52 per share, and held its annual meeting where all management proposals passed and an environmental reporting proposal was rejected. The earnings beat and guidance increase, underpinned by stronger soybean crush, ethanol and Nutrition margins after U.S...

It's been a pretty great week for KLX Energy Services Holdings, Inc. ( NASDAQ:KLXE ) shareholders, with its shares...

One of the biggest stories of last week was how Gambling.com Group Limited ( NASDAQ:GAMB ) shares plunged 47% in the...

Earlier this week, Travel + Leisure Co. and Authentic Brands Group officially launched the Eddie Bauer Adventure Club in Moab, Utah, introducing a 39-suite, outdoor-focused resort that converts Eddie Bauer’s “Live Your Adventure” ethos into an immersive hospitality and vacation ownership experience. The debut adds an adventure-centric, sustainability-minded brand to Travel + Leisure’s portfolio, expanding its reach with experience-hungry travelers and deepening engagement through owner...

KB Home recently opened several new communities across the U.S., including Stevens Ridge in Marysville, Washington, Sunset Oaks and Madera in Texas, and multiple developments in California and Arizona, offering personalized, ENERGY STAR®-designed homes with prices starting from the mid US$200,000s to the US$590,000s range. These geographically diverse launches, all emphasizing efficiency, health-focused features and extensive buyer personalization, highlight KB Home’s continued push into...

In early May 2026, Open Text Corporation reported third-quarter results showing higher revenue of US$1,282.5 million and net income of US$172.65 million year-on-year, affirmed its 2026 earnings guidance for 1% to 2% revenue growth after adjusting for US$30 million of divested sales, completed the sale of its Vertica business, and confirmed a quarterly dividend of US$0.2750 per share payable on June 19, 2026. By exiting the non-core Vertica analytics unit and directing the proceeds toward...

REalloys (ALOY) has moved into focus after a cluster of filings, including full year 2025 results showing US$0.8 million in sales, a US$75.6 million net loss, and management’s updated view on its going concern status. See our latest analysis for REalloys. Since those filings, REalloys’ share price has come under pressure, with a 7 day share price return down 12.64% and a 30 day share price return down 32.55%. The 1 year total shareholder return is very large, which suggests earlier optimism...

Erasca (ERAS) is under pressure after disclosing that Revolution Medicines accused its lead candidate ERAS-0015 of patent infringement and trade secret misappropriation, prompting multiple securities law investigations and raising fresh questions about the program’s long term prospects. See our latest analysis for Erasca. The latest legal headlines arrive after a sharp 43.79% decline in the 30 day share price return. This follows a strong year to date share price return of 184.96% and a very...

There's been a notable change in appetite for Paysafe Limited ( NYSE:PSFE ) shares in the week since its first-quarter...

Earlier in Q2 2026, Welltower reported strong Q1 results, with revenue rising about 40%, senior housing same-store NOI up sharply, and portfolio occupancy improving to roughly 89%, prompting management to raise full-year 2026 normalized FFO guidance while keeping its payout ratio under 50%. This combination of faster growth and a conservative payout suggests management sees room to support dividends while continuing to invest across its healthcare real estate platform. We’ll now explore how...

First quarter earnings shift draws fresh attention to Protagonist Therapeutics Protagonist Therapeutics (PTGX) has moved from a loss to a profit in the first quarter of 2026, reporting net income of US$3.78 million after a net loss of US$11.66 million a year earlier. See our latest analysis for Protagonist Therapeutics. The earnings swing to profit comes after a strong run for investors, with the share price delivering a 25.39% return over the past 90 days and a very large 292.25% total...

In early May 2026, BioCryst Pharmaceuticals reported first-quarter revenue of US$156.41 million but a net loss of US$721.81 million, while maintaining full-year 2026 revenue guidance of US$635 million to US$660 million and announcing a European licensing deal for navenibart that includes a US$70 million upfront payment plus potential milestones and royalties. The navenibart agreement with Neopharmed Gentili’s Irish affiliate both brings immediate capital to BioCryst and outsources European...

Biogen (NasdaqGS:BIIB) is advancing its experimental Alzheimer’s drug diranersen into late stage trials after Phase 2 CELIA data. The therapy, an antisense oligonucleotide that targets tau protein, did not meet the study’s primary endpoint but showed strong biomarker changes and signs of cognitive benefit. The decision extends Biogen’s Alzheimer’s efforts beyond amyloid focused treatments and increases attention on its neurology pipeline. For you as an investor, this keeps Biogen in the...

Magnolia Oil & Gas Corporation ( NYSE:MGY ) shareholders will have a reason to smile today, with the analysts making...

Shareholders might have noticed that Prelude Therapeutics Incorporated ( NASDAQ:PRLD ) filed its first-quarter result...

Today is shaping up negative for LENZ Therapeutics, Inc. ( NASDAQ:LENZ ) shareholders, with the analysts delivering a...

The latest analyst coverage could presage a bad day for Arcus Biosciences, Inc. ( NYSE:RCUS ), with the analysts making...

MSA Safety stock snapshot after recent moves MSA Safety (MSA) has drawn fresh attention after recent price swings, with the stock closing at US$171.24. For investors, the question now is how current valuation aligns with fundamentals. See our latest analysis for MSA Safety. Recent trading has been choppy, with the share price falling 15.2% over the past 90 days but still showing a 5.55% year to date share price return and 8.68% one year total shareholder return. This suggests moderating...